Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Tarsus Pharmaceuticals, Inc.

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18
   8-K10-K10-K10-KS-1/A
Net income  -62.1-13.8-26.8-4.70.0
Depreciation and amortization   0.30.10.00.0
Stock-based compensation   8.50.80.00.0
Change in working capital   [+] 8.17.71.40.1
Other operating activities   0.7-2.9-0.5-1.3
Cash from operations   3.7-21.1-3.7-1.2
   
Capital expenditures   -0.6-0.5-0.20.0
Cash from investing   -0.6-0.5-0.20.0
   
Issuance of common stock, net    91.7  
Option exercises   0.30.0  
Other cash from financing   0.340.159.43.6
Cash from financing   0.0131.859.43.6
   
Free cash flow   3.2-21.6-3.8-1.2
        Per share (diluted)   $0.15($3.48)($1.63)$0.00
   

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy